Category Archives: Research

Ginkgo Biloba Doesn’t Prevent Alzheimer’s

Posted on by

Alzheimer; News from the web:

Well the article in the Huffington post this morning certainly burst the bubble of many people who had relied on this herb.

A trail in France, an article in the Lancet for Neurology and an opinion from the Alzheimer association killed the hype and the consensus is that anyone who buys this over the counter herb in the expectation that it will do anything to slow down or prevent the disease, is wasting their money.

Read all about it HERE

visit us at AlzheimerHeadlines.com

Trouble sleeping? It may be Alzheimer’s

Posted on by

Alzheimer; News from the web:

In a study with mice, the scientists at Washington University School of Medicine in St. Louis found that trouble with sleeping may be an early sign of building up of plaques in the brain that is generally correlated with Alzheimer.

Finding an early signal can be important as it will help keeping the disease under control or at least slowing it down. This in itself does not yet indicate a new way to get to a medicine of some sort.

Read all about it HERE

visit us at AlzheimerHeadlines.com

Alzheimer drugs

Posted on by

Alzheimer; News from the web:

Over at nature they have provided a great overview over the current state of affairs concerning Alzheimer drugs and research.

They also highlight the enormous costs involved in doing the clinical trails and some of the devastating results we saw this summer.

It is difficult to keep investors interested and motivated but lately there are some new paths that may just be worth exploring. Great article

Read all about it HERE

visit us at AlzheimerHeadlines.com

Alzheimer treatment compound found!

Posted on by

Alzheimer; News from the web:

Researchers from Cleveland Clinic’s Lerner Research Institute and Anesthesiology Institute found that the compound MDA7 induced beneficial immune responses that limited the development of Alzheimer’s disease.

Treatment with the compound restored cognition, memory and synaptic plasticity – a key neurological foundation of learning and memory – in an animal model.

“Cleveland Clinic dedicated two years of research into the examination of this compound and our findings show it could represent a novel therapeutic target in the treatment of Alzheimer’s disease,” Mohamed Naguib, lead researcher said in a statement.

Read all about it HERE

visit us at AlzheimerHeadlines.com

New biomarkers offer hope for Alzheimer

Posted on by

Alzheimer; News from the web:

An article has been published as supplement to the Journal of Alzheimer’s disease and it explores the development of imaging-based biomarkers that will have an impact on diagnosis before the disease process is set in motion.

Many of the detection tools we rely on today only help identify the issue once the disease symptoms are clearly visible, this research may provide a new way of detection that may in turn lead to a better understanding of the progression of the disease
.

Read all about it HERE

visit us at AlzheimerHeadlines.com

Possible breakthrough in Alzheimer research

Posted on by

Alzheimer; News from the web:

Scientist at the Harvard Medical School and researchers at the Queensland Brain Institute have found that the size of the mitochondria, the part responsible for metabolising energy in cells, matters and may cause the toxic proteins known as  Beta Amalloyd and Tau.

Apparently the larger the mitochondria the more difficult it is to travel along the nerve cells and those can be one meter in length. In tests with fruit flies and mice they have been able to test this relation between the size of the mitochondria and the incidence of Alzheimer’s disease.

The director of Queensland’s Centre for Ageing Dementia Research, Jurgen Gotz, says scientists have been able to successfully treat abnormal mitochondria in fruit flies and mice.

“By changing their size back to normal it’s possible to restore their function and also to prevent the new ones dying,” he said.

Read all about it HERE

visit us at AlzheimerHeadlines.com